- Home
- ZNTL vs NEWT Comparison
ZNTL vs NEWT Comparison
Compare ZNTL & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- NEWT
- Stock Information
- Founded
- ZNTL 2014
- NEWT 1998
- Country
- ZNTL United States
- NEWT United States
- Employees
- ZNTL N/A
- NEWT N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- ZNTL Health Care
- NEWT Finance
- Exchange
- ZNTL Nasdaq
- NEWT Nasdaq
- Market Cap
- ZNTL 105.8M
- NEWT 294.8M
- IPO Year
- ZNTL 2020
- NEWT N/A
- Fundamental
- Price
- ZNTL $1.42
- NEWT $12.03
- Analyst Decision
- ZNTL Buy
- NEWT Hold
- Analyst Count
- ZNTL 6
- NEWT 4
- Target Price
- ZNTL $6.53
- NEWT $13.00
- AVG Volume (30 Days)
- ZNTL 729.8K
- NEWT 163.1K
- Earning Date
- ZNTL 11-11-2025
- NEWT 11-05-2025
- Dividend Yield
- ZNTL N/A
- NEWT 6.41%
- EPS Growth
- ZNTL N/A
- NEWT 21.23
- EPS
- ZNTL N/A
- NEWT 2.01
- Revenue
- ZNTL $26,865,000.00
- NEWT $364,004,000.00
- Revenue This Year
- ZNTL N/A
- NEWT N/A
- Revenue Next Year
- ZNTL N/A
- NEWT $12.73
- P/E Ratio
- ZNTL N/A
- NEWT $5.89
- Revenue Growth
- ZNTL N/A
- NEWT 20.91
- 52 Week Low
- ZNTL $1.01
- NEWT $9.12
- 52 Week High
- ZNTL $4.46
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.87
- NEWT 52.65
- Support Level
- ZNTL $1.40
- NEWT $11.44
- Resistance Level
- ZNTL $2.02
- NEWT $11.77
- Average True Range (ATR)
- ZNTL 0.11
- NEWT 0.30
- MACD
- ZNTL -0.05
- NEWT -0.04
- Stochastic Oscillator
- ZNTL 4.76
- NEWT 57.28
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.